Cargando…
Growth hormone supplementation ameliorates blastocyst euploidy rates and improves pregnancy outcomes in women undergoing preimplantation genetic testing for aneuploidy cycles
BACKGROUND: Growth hormone (GH) supplementation has been shown to improve oocyte quality and live birth, but few studies have examined whether GH can reduce embryonic aneuploidy. Chromosomal abnormalities in preimplantation embryos have been regarded as the principal cause of implantation failure an...
Autores principales: | Guo, Qingqing, Liu, Peihao, Zhou, Wei, Xia, Mingdi, Li, Jing, Lu, Juanjuan, Ma, Jin-Long, Chen, Zi-Jiang, Yan, Junhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025457/ https://www.ncbi.nlm.nih.gov/pubmed/36950683 http://dx.doi.org/10.3389/fendo.2023.1117706 |
Ejemplares similares
-
Effect of Blastocyst Morphology and Developmental Rate on Euploidy and Live Birth Rates in Preimplantation Genetic Testing for Aneuploidy Cycles With Single-Embryo Transfer
por: Li, Na, et al.
Publicado: (2022) -
Day 7 blastocyst euploidy supports routine implementation for cycles
using preimplantation genetic testing
por: Whitney, John B., et al.
Publicado: (2019) -
Logistic regression analyses of factors affecting the euploidy of blastocysts undergoing in vitro fertilization and preimplantation genetic testing
por: Zhang, Zhiping, et al.
Publicado: (2022) -
Oocytes With Smooth Endoplasmic Reticulum Aggregates May Not Impact Blastocyst Euploidy Rate
por: Xu, Jian, et al.
Publicado: (2022) -
Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist/antagonist protocol
por: Wang, Lu, et al.
Publicado: (2023)